RIPK3 and neoplasm: For example, necroptosis-induced CCL2 release depends on the activation of the receptor interaction protein 1 (RIP1)/RIP3/mixed lineage kinase-like (MLKL) pseudokinase, which may promote the oncogenic phenotype [54] of tumor-associated astrocyte TAA.LncRNA.